Yebra G - Search Results

1

High drug resistance prevalence among vertically HIV-infected patients transferred from pediatric care to adult units in Spain.

de Mulder M, Yebra G, Navas A, de José MI, Gurbindo MD, González-Tomé MI, Mellado MJ, Saavedra-Lozano J, Muñoz-Fernández MÁ, de Ory SJ, Ramos JT, Holguín A; Madrid Cohort of HIV-Infected Children. de Mulder M, et al. Among authors: yebra g. PLoS One. 2012;7(12):e52155. doi: 10.1371/journal.pone.0052155. Epub 2012 Dec 17. PLoS One. 2012. PMID: 23284913 Free PMC article.

2

HIV-1 non-B subtypes: High transmitted NNRTI-resistance in Spain and impaired genotypic resistance interpretation due to variability.

Yebra G, de Mulder M, del Romero J, Rodríguez C, Holguín A. Yebra G, et al. Antiviral Res. 2010 Feb;85(2):409-17. doi: 10.1016/j.antiviral.2009.11.010. Epub 2009 Dec 11. Antiviral Res. 2010. PMID: 20004217

3

The maturation inhibitor bevirimat (PA-457) can be active in patients carrying HIV type-1 non-B subtypes and recombinants.

Yebra G, Holguín A. Yebra G, et al. Antivir Ther. 2008;13(8):1083-5. Antivir Ther. 2008. PMID: 19195334

4

[Epidemiology of drug-resistant HIV-1 transmission in naïve patients in Spain].

Yebra G, Holguín A. Yebra G, et al. Med Clin (Barc). 2010 Oct 16;135(12):561-7. doi: 10.1016/j.medcli.2009.09.029. Epub 2009 Dec 3. Med Clin (Barc). 2010. PMID: 19959197 Review. Spanish.

5

Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.

de Mulder M, Yebra G, Martín L, Prieto L, Mellado MJ, Rojo P, Muñoz-Fernández MÁ, Jiménez de Ory S, Ramos JT, Holguín A; Madrid cohort of HIV-infected children. de Mulder M, et al. Among authors: yebra g. J Antimicrob Chemother. 2011 Oct;66(10):2362-71. doi: 10.1093/jac/dkr305. Epub 2011 Aug 2. J Antimicrob Chemother. 2011. PMID: 21810838

6

Increase of transmitted drug resistance among HIV-infected sub-Saharan Africans residing in Spain in contrast to the native population.

Yebra G, de Mulder M, Pérez-Elías MJ, Pérez-Molina JA, Galán JC, Llenas-García J, Moreno S, Holguín Á. Yebra G, et al. PLoS One. 2011;6(10):e26757. doi: 10.1371/journal.pone.0026757. Epub 2011 Oct 25. PLoS One. 2011. PMID: 22046345 Free PMC article.

7

Trends in drug resistance prevalence in HIV-1-infected children in Madrid: 1993 to 2010 analysis.

de Mulder M, Yebra G, Navas A, Martin L, de Jose MI, Navarro ML, de Ory SJ, Gonzalez-Granado I, Mellado MJ, Ramos JT, Holguin A. de Mulder M, et al. Among authors: yebra g. Pediatr Infect Dis J. 2012 Nov;31(11):e213-21. doi: 10.1097/INF.0b013e3182678c7c. Pediatr Infect Dis J. 2012. PMID: 22785049

8

Description of HIV-1 group M molecular epidemiology and drug resistance prevalence in Equatorial Guinea from migrants in Spain.

Yebra G, de Mulder M, Holguín Á. Yebra G, et al. PLoS One. 2013 May 22;8(5):e64293. doi: 10.1371/journal.pone.0064293. Print 2013. PLoS One. 2013. PMID: 23717585 Free PMC article.

9

Different trends of transmitted HIV-1 drug resistance in Madrid, Spain, among risk groups in the last decade.

Yebra G, Delgado R, Pulido F, Rubio R, Galán JC, Moreno S, Holguín Á. Yebra G, et al. Arch Virol. 2014 May;159(5):1079-87. doi: 10.1007/s00705-013-1933-y. Epub 2013 Dec 3. Arch Virol. 2014. PMID: 24297490

10

Transmitted drug-resistance in human immunodeficiency virus-infected adult population in El Salvador, Central America.

Holguín Á, Yebra G, Martín L, de Pineda AT, Ruiz LE, Quezada AY, Nieto AI, Escobar G. Holguín Á, et al. Among authors: yebra g. Clin Microbiol Infect. 2013 Dec;19(12):E523-32. doi: 10.1111/1469-0691.12264. Epub 2013 Jun 19. Clin Microbiol Infect. 2013. PMID: 23782115 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters